The CDC says prostate cancer is the second leading cause of cancer death in American men, behind lung cancer. With prostate ...

The American Urological Association recommends baseline PSA screening for average-risk men starting at age 45.

I am a healthy 89-year-old United States Army veteran. In August 2017, I was diagnosed with advanced prostate cancer and was ...

Today, the United States celebrates the anniversary of its independence from Great Britain.  Independence Day, also known as ...

A Loughborough University student has developed a new medical device that could transform how prostate health is assessed and ...

A patient shares how an event about clinical trials at Moores Cancer Center brought a community together to educate and ...

Multidisciplinary care, a collaborative approach where various healthcare disciplines come together, is essential for treating those with prostate cancer.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

While the American Cancer Society does not recommend “routine” prostate-specific antigen screening for men, there's a lot to ...

Jason Junkins, M.D., and his wife, Angela For local urgent care physician Jason Junkins, M.D., prostate cancer was not on his ...

Antev is a clinical stage biotech company, developing Teverelix, a next generation GnRH antagonist, as first in market product for high CV -risk prostate cancer patients and patients with first acute ...

By Prof. Raphael Nyarkotey OBU I found that attaya is green tea, and science has demonstrated the numerous benefits of ...